May 25, 2018 - The following slide deck was published by Ligand Pharmaceuticals Incorporated in conjunction with this event.
May 25, 2018 - AbbVie's (ABBV) phase III iLLUMINA study evaluating Imbruvica in combination with Gazyva meets its primary endpoint of improvement in progression-free survival.
May 24, 2018 - Agios (AGIO) has several interesting candidates in its pipeline. However, the company still faces stiff competition.
May 24, 2018 - SWTUY vs. LGND: Which Stock Is the Better Value Option?
May 23, 2018 - Dr. Reddy's bottom line and top line suffered a year-over-year decline, in the fourth quarter of fiscal 2018.
May 23, 2018 - Though Allergan (AGN) boasts a solid underlying business, its stock is down. Here we discuss why.
May 22, 2018 - Entera Bio has filed an amended registration statement reviving its IPO efforts.The firm is advancing a pipeline of hypoparathyroidism and osteoporosis treatment candidates.ENTX has found existing inv
May 22, 2018 - Inovio (INO) begins a phase II study to evaluate the efficacy of its pipeline candidate VGX-3100 on adult men and women with human papilloma virus (HPV)-related anal dysplasia.
May 21, 2018 - Ligand Pharmaceuticals Incorporated is at a 52-week high, but can investors hope for more gains in the future? We take a look at the fundamentals for LGND for clues.
May 21, 2018 - AstraZeneca's (AZN) Lokelma secures an FDA approval for the treatment of hyperkalemia in adults.